Cyclerion Therapeutics (CYCN) Short Interest Ratio & Short Volume → Forget the “Magnificent 7” Tech Companies, Buy This AI Stock Instead (From Banyan Hill Publishing) (Ad) Free CYCN Stock Alerts $3.00 -0.15 (-4.76%) (As of 05/14/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Cyclerion Therapeutics Short Interest DataCurrent Short Volume19,400 sharesPrevious Short Volume20,200 sharesChange Vs. Previous Month-3.96%Dollar Volume Sold Short$56,454.00Short Interest Ratio / Days to Cover7.2Last Record DateApril 30, 2024Outstanding Shares2,710,000 sharesFloat Size1,960,000 sharesShort Percent of Float0.99%Today's Trading Volume654 sharesAverage Trading Volume2,864 sharesToday's Volume Vs. Average23% Short Selling Cyclerion Therapeutics ? Sign up to receive the latest short interest report for Cyclerion Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatCYCN Short Interest Over TimeCYCN Days to Cover Over TimeCYCN Percentage of Float Shorted Over Time Ad Chaikin AnalyticsDid Intel Just Dethrone Nvidia?Intel (INTC) just announced a brand-new AI venture - the Aurora supercomputer. This computer was specifically designed for artificial intelligence and is now the fastest AI-centered computer on the planet. You can get all the details here. Cyclerion Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202419,400 shares $56,454.00 -4.0%1.0%7.2 $2.91 4/15/202420,200 shares $69,488.00 -8.6%1.0%7 $3.44 3/31/202422,100 shares $70,720.00 -6.0%1.2%7.4 $3.20 3/15/202423,500 shares $76,375.00 -4.9%1.3%7.8 $3.25 2/29/202424,700 shares $74,100.00 -7.8%1.3%4.2 $3.00 2/15/202426,800 shares $76,648.00 +9.8%1.6%3.6 $2.86 Get the Latest News and Ratings for CYCN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cyclerion Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/31/202424,400 shares $73,200.00 -5.8%1.4%3.1 $3.00 1/15/202425,900 shares $94,535.00 -15.1%1.5%3.4 $3.65 12/31/202330,500 shares $102,175.00 +1.0%1.7%3.5 $3.35 12/15/202330,200 shares $82,748.00 +87.6%1.7%3.5 $2.74 11/30/202316,100 shares $34,776.00 +21.1%0.9%2.2 $2.16 11/15/202313,300 shares $25,403.00 -14.2%0.7%2.1 $1.91 10/31/202315,500 shares $40,300.00 -13.9%0.8%2.2 $2.60 10/15/202318,000 shares $61,380.00 +13.2%0.9%2.1 $3.41 9/30/202315,900 shares $54,378.00 -14.5%0.8%1.8 $3.42 9/15/202318,600 shares $69,750.00 +5.7%1.0%1.8 $3.75 8/31/202317,600 shares $63,184.00 -31.8%0.8%1.6 $3.59 8/15/202325,800 shares $94,428.00 +23.4%1.2%2.1 $3.66 7/31/202320,900 shares $64,790.00 -37.8%1.0%0.7 $3.10 7/15/202333,600 shares $137,760.00 +20.0%1.6%1.1 $4.10 6/30/202328,000 shares $115,080.00 -22.7%1.2%1 $4.11 6/15/202336,200 shares $167,244.00 No Change1.7%1 $4.62 5/31/202336,200 shares $157,480.86 +168.2%1.9%1 $4.35 5/15/202313,500 shares $51,624.00 No Change0.8%0.4 $3.82 10/31/2022445,800 shares $245,190.00 +202.2%N/A2.1 $0.55 10/15/2022147,500 shares $61,404.25 -23.0%N/A0.7 $0.42 9/30/2022191,600 shares $164,776.00 -28.2%N/A1.3 $0.86 9/15/2022267,000 shares $245,613.30 +29.4%N/A1.7 $0.92 8/31/2022206,300 shares $173,292.00 +23.1%N/A0.8 $0.84 8/15/2022167,600 shares $149,164.00 -17.6%N/A0.6 $0.89 7/31/2022203,500 shares $195,360.00 -16.7%N/A0.8 $0.96 7/15/2022244,400 shares $221,426.40 -7.7%N/A1 $0.91 6/30/2022264,700 shares $145,267.36 +4.7%N/A1.1 $0.55 6/15/2022252,800 shares $122,987.20 +12.2%N/A1 $0.49 5/31/2022225,400 shares $140,334.04 -11.5%N/A1.7 $0.62 5/15/2022254,800 shares $143,962.00 -10.8%N/A2.2 $0.57 4/30/2022285,500 shares $210,270.75 -17.4%N/A2.4 $0.74 4/15/2022345,500 shares $345,500.00 -5.8%N/A2.6 $1.00 3/31/2022366,800 shares $407,148.00 -6.9%N/A2.6 $1.11 3/15/2022393,800 shares $393,800.00 -20.1%N/A2.2 $1.00Trump’s Former Wingman Bets Big on AI (Ad)One of his AI company’s earliest investors was the CIA’s venture capital arm called In-Q-Tel … named after Q, the fictional character who makes gadgets for James Bond. Soon, an alphabet soup of 30 government agencies would entrust the company with their most sensitive information.Get the full story here. CYCN Short Interest - Frequently Asked Questions What is Cyclerion Therapeutics' current short interest? Short interest is the volume of Cyclerion Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 19,400 shares of CYCN short. 0.99% of Cyclerion Therapeutics' shares are currently sold short. Learn More on Cyclerion Therapeutics' current short interest. What is a good short interest ratio for Cyclerion Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CYCN shares currently have a short interest ratio of 7.0. Learn More on Cyclerion Therapeutics's short interest ratio. Which institutional investors are shorting Cyclerion Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Cyclerion Therapeutics: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Cyclerion Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.99% of Cyclerion Therapeutics' floating shares are currently sold short. Is Cyclerion Therapeutics' short interest increasing or decreasing? Cyclerion Therapeutics saw a drop in short interest in the month of April. As of April 30th, there was short interest totaling 19,400 shares, a drop of 4.0% from the previous total of 20,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Cyclerion Therapeutics' float size? Cyclerion Therapeutics currently has issued a total of 2,710,000 shares. Some of Cyclerion Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Cyclerion Therapeutics currently has a public float of 1,960,000 shares. How does Cyclerion Therapeutics' short interest compare to its competitors? 0.99% of Cyclerion Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Cyclerion Therapeutics: Trevena, Inc. (0.08%), Vaxxinity, Inc. (3.61%), Bionomics Limited (1.45%), eFFECTOR Therapeutics, Inc. (3.12%), Oragenics, Inc. (2.07%), Virios Therapeutics, Inc. (1.24%), Hepion Pharmaceuticals, Inc. (1.19%), Cadrenal Therapeutics, Inc. (0.80%), Shuttle Pharmaceuticals Holdings, Inc. (0.74%), Pasithea Therapeutics Corp. (1.34%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Cyclerion Therapeutics stock? Short selling CYCN is an investing strategy that aims to generate trading profit from Cyclerion Therapeutics as its price is falling. CYCN shares are trading down $0.15 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Cyclerion Therapeutics? A short squeeze for Cyclerion Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CYCN, which in turn drives the price of the stock up even further. How often is Cyclerion Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CYCN, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Trevena Short Squeeze Vaxxinity Short Squeeze Bionomics Short Squeeze eFFECTOR Therapeutics Short Squeeze Oragenics Short Squeeze Virios Therapeutics Short Squeeze Hepion Pharmaceuticals Short Squeeze Cadrenal Therapeutics Short Squeeze Shuttle Pharmaceuticals Short Squeeze Pasithea Therapeutics Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CYCN) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldForget the “Magnificent 7” Tech Companies, Buy This AI Stock InsteadBanyan Hill PublishingWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsGold Set to EXPLODE!Gold Safe ExchangeThe Crypto 9-5 Escape PlanCrypto 101 MediaThe A.I. story nobody is telling you (Read ASAP)TradeSmithBuy this small stock before coming AI Tidal WaveChaikin AnalyticsElon’s New Device is About to Shock the WorldInvestorPlace